ImmunityBio, Inc. (IBRX) Class Action Lawsuit (March 2026)

In Litigation

2:26cv3261 • March 26, 2026

Class Period Start

January 19, 2026

Class Period End

March 24, 2026

PSLRA Deadline

May 26, 2026

Case Allegations

10b5

Statutes of Repose

Jan 19, 2029

Country

United States

Court

Federal Court

Docket History

Nov 12, 2026

Motion to Dismiss (opens in a new tab)

After reviewing the complaint(s) filed by plaintiffs, defendants have filed a motion requesting that the court dismiss some or all of the plaintiffs' claims. In a motion to dismiss, defendants might challenge the validity of plaintiffs' claims or adequacy of plaintiffs' pleadings. Once a motion to dismiss is filed, the judge will make a decision on whether part or all of the case should be dismissed or the case can proceed as alleged.

Oct 22, 2026

Second Amended Complaint (opens in a new tab)

A new complaint has been filed on behalf of certain investors in ImmunityBio, Inc.. Amended complaints may contain additional facts, parties, allegations, a change in the class definition, etc.

Sep 14, 2026

Motion to Dismiss (opens in a new tab)

After reviewing the complaint(s) filed by plaintiffs, defendants have filed a motion requesting that the court dismiss some or all of the plaintiffs' claims. In a motion to dismiss, defendants might challenge the validity of plaintiffs' claims or adequacy of plaintiffs' pleadings. Once a motion to dismiss is filed, the judge will make a decision on whether part or all of the case should be dismissed or the case can proceed as alleged.

Aug 14, 2026

First Amended Complaint (opens in a new tab)

A new complaint has been filed on behalf of certain investors in ImmunityBio, Inc.. Amended complaints may contain additional facts, parties, allegations, a change in the class definition, etc.

Jul 15, 2026

Appointment of Lead Plaintiff (opens in a new tab)

The court has appointed a lead plaintiff to represent the interests of investors in the lawsuit. The lead plaintiff works with the attorneys handling the case, helps oversee the litigation, and represents the interests of the proposed class.

Mar 26, 2026

First Filed Complaint (opens in a new tab)

A securities fraud class action complaint has been filed on behalf of certain investors in ImmunityBio, Inc..